Company / Shares Outstanding
Allogene Therapeutics, Inc. Shares Outstanding History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
212.2M
FY2025
5-year range
140.5M / 212.2M
FY2021-FY2025
Trend
+25.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 4 consecutive years, from 140474305.00 in FY2021 to 212210597.00 in FY2025.
Based on SEC 10-K filings.
212210597.00 in FY2025 with a 3-year CAGR of +14.2%.
Increased from 143569902.00 to 212210597.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Allogene Therapeutics, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2025, shares outstanding increased 25.8% year-over-year.
- Lowest shares outstanding in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 212.2M | +25.8% |
| FY2024 | 168.6M | +17.5% |
| FY2023 | 143.6M | +0.7% |
| FY2022 | 142.6M | +1.5% |
| FY2021 | 140.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026